Abstract:Alternative splicing is crucial for increasing eukaryotic cell transcriptome and proteome diversity Changes in alternative splicing play a key role in cell differentiation and tissue development, and aberrations in this process have been associated with diseases Despite its importance, the exact mechanisms for regulating alternative splicing are poorly understood Several epigenetic marks, such as histone modification H3K36me3, have previously been associated with changes in alternative splicing Here, we leverage the EpiATLAS data set to systematically re-evaluate evidence for epigenetic control of alternative splicing. We used SUPPA2 to calculate percentage spliced-in (PSI) values for skipped exons and retained introns and integrated this information with histone ChIP-seq and DNA methylation data In addition to genome-wide association analysis with partial correlation and machine learning, we perform locus-specific PSI modeling on individual alternative splicing events The latter represents a new contribution enabled by the unprecedented number of uniformly processed datasets in EpiATLAS. Our results confirm previously reported global associations of DNAm and H3K36me3 for exon inclusion and emphasize the importance of intrinsic features for genome-wide associations. On an event-specific level, trying to identify co-transcriptionally spliced events with epigenetic influence, we show that overall gene expression biases locus-specific analyses Further, we show that epigenetic signal can predict PSI value in cis and trans, indicating sample-specific epigenetic fingerprints that distort across-sample analyses Specifically, generalized linear models select epigenetic features predictive for PSI values not only in their genomic vicinity but also on different chromosomes. Our study demonstrates that epigenetic marks are associated with the alternative inclusion of exons and introns Without a mechanistic explanation for these associations, our work emphasizes the need for more detailed research into the relationship between epigenetic changes and transcriptome diversity.

Epigenetic features are significantly associated with alternative splicing

Epigenetic Regulation of Alternative Splicing.

Alternative splicing at GYNNGY 5' splice sites: more noise, less regulation.

Revisiting Evidence for Epigenetic Control of Alternative Splicing

Chromatin and Genomic determinants of alternative splicing.

Histone Modifications Influence Skipped Exons Inclusion

Computational Analysis Reveals a Correlation of Exon-Skipping Events with Splicing, Transcription and Epigenetic Factors.

Genome-wide Analysis Reveals the Association Between Alternative Splicing and DNA Methylation Across Human Solid Tumors

Multiphasic and Dynamic Changes in Alternative Splicing During Induction of Pluripotency Are Coordinated by Numerous RNA-Binding Proteins.

Investigation of the Mechanism of Alternative Promoters Influencing Alternative Splicing

Specific histone modifications associate with alternative exon selection during mammalian development

Correlations Between the Characteristics of Alternative Splicing Events, Prognosis, and the Immune Microenvironment in Breast Cancer

Alternative splicing links histone modifications to stem cell fate decision

Clusterization in acute myeloid leukemia based on prognostic alternative splicing signature to reveal the clinical characteristics in the bone marrow microenvironment

Global dissection of alternative splicing in paleopolyploid soybean.

Identification of a comprehensive alternative splicing function during epithelial-mesenchymal transition

Global impact of unproductive splicing on human gene expression

Analysis of Colorectal Cancer-Associated Alternative Splicing Based on Transcriptome.

Prognostic Alternative Mrna Splicing Signatures and Associated Splicing Factors in Acute Myeloid Leukemia.

Alternative splicing and related RNA binding proteins in human health and disease

Computational approaches for detecting disease-associated alternative splicing events